Stocks
G1 Therapeutics (GTHX) EV/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -5.67 | -5.22 | -2.03 | -1.30 | -3.40 | -3.10 | ||
| Changes by years, y/y, % | +89% | -8% | -61% | -36% | +161% | +2.5% | |||
G1 Therapeutics. EV/EBITDA
G1 Therapeutics. EV/EBITDA, changes, %
G1 Therapeutics (GTHX) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EV/EBITDA | ? | -0.24 | -1.28 | 0.26 | -3.61 | -9.75 | -3.10 | |
| Changes by years, y/y, % | -82% | +39% | -108% | +157% | +3 907% | |||
| Changes by quarters, q/q, % | -83% | +425% | -120% | -1 488% | +170% | |||
